Ighama-Amegar Ibilola A MD - Newark, New Jersey 07112

Ighama-Amegar Ibilola A MD is categorized under Doctors in Newark, NJ .

Business Name: Ighama-Amegar Ibilola A MD
Contact Person: Ibilola Ighama-Amegar
Address: 88 Chancellor Avenue, Newark, New Jersey 07112
Phone Number: (973) 926-4400
Annual Revenue (USD): $500.000 to $999.999
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Doctors
SIC Code: 8011
NAICS Code: 6211110
Share This Business:
Related Businesses: Johnson Clive L DO - Newark, NJ 07112
Labinson Robert M MD - Newark, NJ 07112
Riaz Najeeb MD - Newark, NJ 07112
Zarzuela Arminia MD - Newark, NJ 07112
Zwolska Barbara MD - Newark, NJ 07112
Shariati Nazly M MD - Newark, NJ 07112
Kuo Howard MD - Newark, NJ 07112
Zaidi Wahaj M MD - Newark, NJ 07112
Perotte Schubert MD - Newark, NJ 07112
Ramachandran Radha MD - Newark, NJ 07112
Kansagara Ketan MD - Newark, NJ 07112
Vyas Shfali MD - Newark, NJ 07112
Koscica Karen DO - Newark, NJ 07112
Shields Stephen D MD - Newark, NJ 07112
Feingold David MD - Newark, NJ 07112
Sivitz Adam B MD - Newark, NJ 07112
Ortiz Carmen MD - Newark, NJ 07112
Ostella Frank M DO - Newark, NJ 07112
Lovelace Akinyele K DO - Newark, NJ 07112
Mojares Gregg DO - Newark, NJ 07112

The company Ighama-Amegar Ibilola A MD provides B2C services in the form of Doctors from its single location in New Jersey. 1 to 4 employees work for Ighama-Amegar Ibilola A MD, and the business now earns $500.000 to $999.999 per annum.

Ighama-Amegar Ibilola A MD was launched in 0 and is classified under SIC code and category 8011 , and NAICS number and grouping 6211110 . To contact Ighama-Amegar Ibilola A MD, please call Ibilola Ighama-Amegar with the phone number (973) 926-4400 or visit its single location at 88 Chancellor Avenue in Newark, New Jersey 07112.

The location of the single location can also be found using the coordinates 40.7044,-74.2132. Read more details about this business on the webpage or follow the company’s social media accounts, on Twitter and on Facebook.